Stay updated with breaking news from Xlife Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Xlife Sciences AG / Key word(s): Miscellaneousalytas therapeutics collaborates with spin-off from the German Diabetes Center 28.11.2022 / 07:00 CET/CESTXlife Sciences’ (SIX: XLS) portfolio company alytas therapeutics (located in Jena, Germany) explores innovative, antibody-based therapeutic concepts for treatment of...
Xlife Sciences AG / Key word(s): Miscellaneous21-Nov-2022 / 07:01 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.The Board of Directors of Xlife Sciences AG (SIX: XLS), a leading European life sciences incubator and accelerator ba...
Xlife Sciences AG / Key word(s): Miscellaneous ProcCluster® from portfolio company inflamed pharma granted US patent 01.1...
M&A deals in Switzerland soared in 2021, which was a record year for M&A deal activity across all sectors. Switzerland’s M&A activity started strong…
M&A deals in Switzerland soared in 2021, with the past year being a record year for M&A deal activity across all sectors. Switzerland’s M&A activity…